Citalopram oxalate
Based on 2 publication(s) in Google Scholar
Citalopram oxalate is a serotonin uptake inhibitor that serves as an antidepressant, effectively reducing ethanol uptake in alcoholics and offering a preferable option for depressed patients experiencing tardive dyskinesia compared to tricyclic antidepressants, which may worsen this condition.
For research use only. We do not sell to patients.
- CAS No.: 207559-01-1
- Formula: C22H23FN2O5
- Molecular Weight:414.43
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Citalopram oxalate
More-
WB
-
WB
Biological Activity
Chemical Information
-
CAS No. 207559-01-1
-
Molecular Weight 414.43
-
Formula C22H23FN2O5
-
SMILES
N#CC1=CC=C2C(COC2(CCCN(C)C)C3=CC=C(C=C3)F)=C1.O=C(C(O)=O)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Comput Struct Biotechnol J
Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor. [Abstract]2023 Jul 7:21:3490-3502. PMID: 37484490
Citalopram oxalate purchased from MedChemExpress. Usage Cited in: Comput Struct Biotechnol J. 2023 Jul 7:21:3490-3502. [Abstract]
Western blot analysis of NLRP3 inflammasome-related protein expression in Citalopram-treated HK-2 cells at concentrations of 0, 10, 20, and 40 μM. GAPDH was used as the internal control. The LPS+ATP-induced NLRP3 inflammasome in HK-2 cells was incubated with the test compounds and LPS (2 μg/mL) for 24 h and subsequently treated with ATP (4 mM) for 2 h. # p < 0.05 compared with the LPS+ATP group. * p < 0.05 compared with the control group. Data are shown as the means ± standard deviations of three individual experiments, n = 3.
Citalopram oxalate purchased from MedChemExpress. Usage Cited in: Comput Struct Biotechnol J. 2023 Jul 7:21:3490-3502. [Abstract]
Expression levels of fibrosis-related proteins in HK-2 cells via western blot analysis. Cells were treated with Citalopram at concentrations of 0, 10, 20 and 40 μM for 24 h. GAPDH was regarded as the internal control. The fibrosis in drug-treated HK-2 cells was treated with TGF-β1 (15 ng/mL) and subsequently incubated for 24 h.
-
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)